Dr. Sander S. Florman, MD

Dr. Florman practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Florman's NPI, 1972695492, was assigned on September 29, 2006. Dr. Florman graduated from University Of Louisville School Of Medicine in 1994. Dr. Florman holds New York license 202917.

Dr. Florman's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Florman also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Florman's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Florman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Florman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Florman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Florman is licensed in New York.

CMS data shows 34 Medicare services from Dr. Florman across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $3,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Florman in 2024. The largest group is under 65, with 16 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 52% are also on Medicaid. Their average risk score is 6.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Florman's median patient age at 56, with 44% women.

In 2016, Dr. Florman wrote 17 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $124 in total drug cost.

Dr. Florman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 160 papers to Dr. Florman, published from 2011 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Liver Transplantation, Kidney Transplantation and Graft Survival. Dr. Florman has published most often in Clin Transplant. Dr. Florman's most frequent co-authors are Thomas D. Schiano, MD, Parissa Tabrizian, MD and Myron Eliot Schwartz, MD.

Dmand AI links Dr. Florman to 10 clinical trials, 2 of them phase 4 studies. 3 are still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome, Carcinoma, Hepatocellular and Liver Neoplasms. TransMedics sponsors the most, 3.

CMS Open Payments shows 18 general payments to Dr. Florman from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Bristol-Myers Squibb Company paid the most, $5,193.

Dr. Florman graduated from University Of Louisville School Of Medicine in 1994.